Distribuzione geografica
Continente #
EU - Europa 236
NA - Nord America 167
AS - Asia 67
OC - Oceania 23
SA - Sud America 10
AF - Africa 6
Totale 509
Nazione #
US - Stati Uniti d'America 145
GB - Regno Unito 88
IT - Italia 59
DE - Germania 36
AU - Australia 23
CA - Canada 20
TR - Turchia 17
FR - Francia 13
FI - Finlandia 12
HK - Hong Kong 8
IN - India 7
JP - Giappone 7
NL - Olanda 7
SG - Singapore 6
BR - Brasile 4
ID - Indonesia 4
UA - Ucraina 4
CL - Cile 3
CN - Cina 3
IR - Iran 3
PL - Polonia 3
SA - Arabia Saudita 3
AR - Argentina 2
BE - Belgio 2
CH - Svizzera 2
KZ - Kazakistan 2
MA - Marocco 2
PA - Panama 2
RU - Federazione Russa 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BG - Bulgaria 1
CY - Cipro 1
ET - Etiopia 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
Totale 509
Città #
London 76
Rome 34
Council Bluffs 32
San Francisco 31
Toronto 17
Canberra 12
Helsinki 12
Seelze 9
Ashburn 8
New York 8
Melbourne 7
Amsterdam 6
Los Angeles 6
Redmond 6
Singapore 6
Tokyo 6
Paris 5
Central 4
Frankfurt am Main 4
Sydney 4
Brownsville 3
Haikou 3
Riyadh 3
Warsaw 3
Anderlecht 2
Andover 2
Berlin 2
Boydton 2
Cinisello Balsamo 2
Delhi 2
Falls Church 2
Ferrara di Monte Baldo 2
Foligno 2
Hanover 2
Houston 2
Kharkiv 2
Newark 2
Perugia 2
Rabat 2
São Paulo 2
Torino 2
Almere Stad 1
Boardman 1
Bratislava 1
Budapest 1
Chantilly 1
Charlotte 1
Chisinau 1
Ciampino 1
Cleveland 1
Cold Lake 1
Dhaka 1
Dublin 1
Fairport 1
Freetown 1
Gauteng 1
Hyderabad 1
Jena 1
Jersey City 1
Johannesburg 1
Kyiv 1
Lima 1
Lincoln 1
Luxembourg 1
L’Aquila 1
Markham 1
Miami 1
Nicosia 1
Panama City 1
Redwood City 1
Reykjavik 1
San Antonio 1
Sarajevo 1
Secaucus 1
Sewanee 1
Siena 1
Sofia 1
Stoney Creek 1
Stow 1
Surabaya 1
Tappahannock 1
Taranto 1
Temecula 1
Turin 1
Zurich 1
Totale 383
Nome #
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 12
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 11
Reply 9
The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen 9
Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank 9
Prognostication in NAFLD: physiological bases, clinical indicators, and newer biomarkers 8
non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores. 8
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores 8
Effect of sibutramine on plasma C-reactive protein, leptin and adiponectin concentrations: a systematic review and meta-analysis of randomized controlled trials 7
Tubercolomi cerebrali multipli resistenti alla terapia convenzionale in un soggetto immunosoppresso [Multiple cerebral tuberculomas resistant to conventional therapy in an immunocompromised subject] 7
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 7
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 7
The Origins of NAFLD: The Potential Implication of Intrauterine Life and Early Postnatal Period 7
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 6
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 6
Angiogenic cytokines in patients undergoing antiviral treatment for chronic hepatitis C virus infection 6
The pharmacological treatment of chronic comorbidities in COPD: mind the gap! 6
Anti-tumor necrosis factor-alpha reverts growth hormone resistance associated with inflammatory bowel disease 6
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial 6
[67 year old man with abdominal pain, anorexia and low-grade fever] 6
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease 6
Reply to the Letter: “Low levels of transaminase and mortality risk in older people with special reference to sarcopenia” 6
Reply 5
The Role of Ribavirin in the Combination Therapy of Hepatitis C Virus Infection 5
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 5
Subcellular shift of the hepatic growth hormone receptor with progression of hepatitis C virus-related chronic liver disease 5
Retroperitoneal fibrosis and ankylosing spondylitis: which links? 5
Iloprost: an adjunctive approach to chronic viral hepatitis treatment 5
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 5
GH-resistance in different stages of chronic liver disease 5
Growth hormone-stimulated insulin-like factor-1 and acid labile subunit in chronic liver disease 5
Determinants of alanine aminotransferase levels in a large population from Southern Italy: relationship between alanine aminotransferase and age 5
Factors enhancing treatment of hepatitis C virus⇓infected italian people who use drugs: The CLEO-GRECAS experience 5
Liver involvement in the course of thymoma-associated multiorgan autoimmunity: The first histological description 5
Combined evaluation of aminotransferases improves risk stratification for overall and cause-specific mortality in older patients 5
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 5
Thrombocytopenia in chronic liver disease: Physiopathology and new therapeutic strategies before invasive procedures 4
Current Treatment Options for HCC: From Pharmacokinetics to Efficacy and Adverse Events in Liver Cirrhosis 4
Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertension 4
A mocking finding: portal cavernoma mimicking neoplastic mass. First sign of myeloproliferative disorder in a patient with Janus kinase2 V617F mutation 4
[A 61-year-old woman with abdominal pain and urination disorders] 4
The hepatic expression of lysosomal acid lipase (LAL) is reduced in NAFLD patients, and associated with features of genetically determined LAL deficiency and NAFLD activity score 4
Lipophagy Impairment Is Associated With Disease Progression in NAFLD 4
Granulomatous thyroiditis: an unexpected finding leading to the diagnosis of sarcoidosis 4
A 67 year old man with abdominal pain, anorexia and low-grade fever 4
Peripheral graft infection due to Staphylococcus aureus without abnormal findings by 99mTc-HMPAO-labeled-leukocyte scan 4
Identification of Fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure 4
A case of Henoch-Schönlein purpura in the elderly: not just a 'second childhood' 4
Molecular and histological traits of reduced lysosomal acid lipase activity in the fatty liver 4
A Genetic and Metabolic Staging System for Predicting the Outcome of Nonalcoholic Fatty Liver Disease 4
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management 4
An overview of deregulated lipid metabolism in nonalcoholic fatty liver disease with special focus on lysosomal acid lipase 3
Lower schooling, higher hepatitis C virus prevalence in Italy: an association dependent on age 3
Gas exchanges and pulmonary vascular abnormalities at different stages of chronic liver disease 3
Hepatitis C treatment in the elderly: New possibilities and controversies towards interferon-free regimens 3
TNF-alpha and growth hormone resistance in patients with chronic liver disease 3
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b 3
A challenging alfa-fetoprotein in a cirrhotic patient 3
The role of intestinal microbiota in the pathogenesis of NAFLD: starting points for intervention 3
Hepatitis C and double-hit B cell lymphoma successfully treated by antiviral therapy 3
Hepatocellular carcinoma in alcoholic liver disease: current management and recent advances 3
Role of SIRT-3, p-mTOR and HIF-1 in hepatocellular carcinoma patients affected by metabolic dysfunctions and in chronic treatment with metformin 3
Haemorrhoidal disease in severe portal hypertension: a combined approach with transjugular intrahepatic portosystemic shunt (TIPS) and transanal haemorrhoidal dearterialization (THD) 3
[Ramipril and new therapeutic possibilities for ACE-inhibitors] 3
Portal diameter in the diagnosis of esophageal varices in 266 cirrhotic patients: which role? 3
Hepatitis C virus-related B cell subtypes in non Hodgkin's lymphoma 3
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 3
Liver cirrhosis after prolonged therapy with IFN-alpha plus interleukin-2 in a metastatic renal cancer long-term survivor 3
Association between non-invasive liver fibrosis scores and occurrence of health adverse outcomes in older people 3
Breath-print analysis by e-nose may refine risk stratification for adverse outcomes in cirrhotic patients 3
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 3
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 3
Assessment of liver function by the exhaled breath-print during chronic liver disease 3
Altered metal metabolism in patients with HCV-related cirrhosis and hepatic encephalopathy 3
Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis - Response to Lecube et al. 3
AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement 3
Reelin expression in human liver of patients with chronic hepatitis C infection 3
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 3
The hepatic expression of GH/IGF1 axis components is impaired with fibrosis progression in patients with HCV-related chronic hepatitis 3
Hepatic matrix metalloproteinase-10 exerts a hepatoprotective role after acute liver inury 3
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia. 3
Donna di 35 anni con febbre, dispnea e dolore alla coscia sinistra [A 35-year-old woman with fever, dyspnea, and pain in the left thigh]. 3
Interplay between SIRT-3, metabolism and its tumor suppressor role in hepatocellular carcinoma 3
Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair 3
Association between clinical scores of liver fibrosis and adverse non-hepatic outcomes: The key in the holistic vision of the patient 3
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 3
Inborn and acquired risk factors for severe liver disease in Europeans with type 2 diabetes from the UK Biobank 3
What changed in the Italian internal medicine and geriatric wards during the lockdown 3
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 3
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry 2
The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis 2
Hepatic toll-like receptor 4 expression is associated with portal inflammation and fibrosis in patients with NAFLD 2
Hepatic complications of bariatric surgery : the reverse side of the coin 2
Proton pump inhibitor prescription abuse and sepsis in cirrhosis 2
The antineoplastic role of bisphosphonates: from basic research to clinical evidence 2
Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: a case report 2
Totale 435
Categoria #
all - tutte 21.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.577

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022345 0 2 8 0 3 3 2 6 47 4 4 266
2022/2023117 13 1 7 4 10 2 30 4 3 5 34 4
2023/202489 36 51 2 0 0 0 0 0 0 0 0 0
Totale 551